Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report

Figure 1 Chest computed tomography scan. A: At presentation, the computed tomography (CT) of the patient showed consolidation, ground-glass opacity, and mucoid impaction in the right upper lung; B: Grocott’s staining of the mucoid impaction tissue showed septate fungal hyphae, and Aspergillus fumigatus was confirmed by culture; C and D: Chest CT during the third recurrence of allergic bronchopulmonary aspergillosis showing mucoid impaction in the upper lobe of the right lung and lower lobe of the left lung; E and F: The CT findings in C and D disappeared 1 mo after dupilumab administration.

Figure 2 Laboratory data and dose of oral prednisolone. Changes in the serum total immunoglobulin E (IgE) levels, peripheral blood eosinophil count and dose of oral corticosteroids (OCS).